Loading...
Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib
The cholesterol ester transfer protein (CETP) inhibitor dalcetrapib has been under evaluation for its potential to prevent cardiovascular (CV) events for almost two decades. The current clinical development program, representing new advances in precision medicine and focused on a genetically defined...
Na minha lista:
| Udgivet i: | Clin Pharmacokinet |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6182459/ https://ncbi.nlm.nih.gov/pubmed/29730761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-018-0656-3 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|